Triumeq 600-50-300 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXR8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,669
Award facts
- Contract value 100% obligated
- $23,668.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23.7K delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of February 2, 2026, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's medical supply chain responsibilities in provisioning pharmaceuticals for military healthcare systems and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 2031. This comprehensive IDC serves as the primary vehicle enabling Cencora and its subsidiaries to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs globally. The non-set-aside status of this award indicates that AmerisourceBergen successfully competed on a full and open basis, consistent with the company's established role as a critical vendor in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FXR8L?
SPE2DR26FXR8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FXR8L worth?
The government has obligated $23,669 on SPE2DR26FXR8L.
Is contract SPE2DR26FXR8L an order under another contract?
Yes. SPE2DR26FXR8L is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR8L competed?
The extent of competition for SPE2DR26FXR8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award